FHA
LUCD icon

Flagship Harbor Advisors’s Lucid Diagnostics LUCD Stock Holding History

Flagship Harbor Advisors’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$3.27K – 1568
2025
Q4 		$3.27K Buy
+3,000
New +$3.35K ﹤0.01% 1747

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Flagship Harbor Advisors's LUCD Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Lucid Diagnostics (LUCD) in Q1 2026, closing a stake of 3,000 shares — an estimated $3.27K sold.

Flagship Harbor Advisors first reported a position in LUCD in Q4 2025 and held it in 1 quarter. The position peaked at $3.27K in Q4 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Lucid Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 3,000 Lucid Diagnostics shares in Q1 2026, an estimated $3.27K.
  • Flagship Harbor Advisors first reported a position in Lucid Diagnostics in Q4 2025 and held it in 1 quarter.
  • Flagship Harbor Advisors's Lucid Diagnostics position peaked at $3.27K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.